Skip to content

Sonoco Products SON Occupancy and equipment

Occupancy and equipment at other companies

West Pharmaceutical Services logo
West Pharmaceutical ServicesWST

Other financials

Income statement

See full
Revenue$1.7B-1.9%
Gross profit$345.6M-2.3%
Operating income$127.1M+0.2%
Net income$67.6M+24.2%
EPS (diluted)$0.68+23.6%

Balance sheet

See full
Cash & equivalents$224.5M+17.1%
Total debt$6.3B-35.2%
Total equity$3.6B+45.8%
Total assets$11.1B-12.7%

Cash flow

See full
Operating cash flow-$367.9M-76.8%
CapEx$62.1M-33.0%
Free cash flow-$430.0M-43.0%

Valuation

See full
Market cap$5.01B+14.5%
Enterprise value$11.05B-19.5%
P/E4.9×-23.6×
P/S0.7×-0.1×

Profitability

See full
Gross margin20.9%-0.5pp
Operating margin13.6%+6.9pp
Net margin13.6%+10.9pp
FCF margin2.9%+1.8pp

Returns & leverage

See full
Return on equity33.8%+27.5pp
Debt / equity1.8×-2.2×
Current ratio+0.2×

Where this comes from

Reported directly by Sonoco Products in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseCost.

The official record: Sonoco Products’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →

Ask your AI about Sonoco Products's occupancy and equipment.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Sonoco Products's occupancy and equipment?
Sonoco Products (SON) reported occupancy and equipment of $15.14M in Q1 2026.
How has Sonoco Products's occupancy and equipment changed year-over-year?
Sonoco Products's occupancy and equipment decreased by 2.2% year-over-year, from $15.48M to $15.14M.
What does occupancy and equipment mean?
Costs for office and branch facilities (rent, utilities, maintenance) and equipment (depreciation, repairs, technology hardware) used in operations.